Diet, microbiome, and colorectal cancer

Area of Science:

• Microbiology
• Oncology
• Gastroenterology

Background:

• Growing scientific interest in the colorectal cancer (CRC) microbiome over the last decade.
• The human microbiome and its products are implicated in CRC-related pathogenic inflammation.
• Specific dietary influences on the gut microbial community may protect against CRC risks.

Purpose of the Study:

• To review the current understanding of the CRC-associated microbiome.
• To summarize dietary strategies relevant to CRC prevention and management.
• To highlight the microbiome's dual role as a CRC contributor and a preventive tool.

Main Methods:

• Literature review of scientific publications on CRC and the microbiome.
• Analysis of studies investigating the link between gut microbiota and CRC.
• Synthesis of research on dietary interventions and their impact on the CRC microbiome.

Main Results:

• The microbiome plays a significant role in CRC pathogenesis and progression.
• Dietary modulation of the gut microbiome shows potential for CRC risk reduction.
• The gut microbiota is a key factor in both CRC development and prevention.

Conclusions:

• The microbiome is a critical factor in colorectal cancer.
• Dietary strategies targeting the microbiome may reduce CRC risk and improve patient quality of life.
• Future research may lead to novel microbiome-based treatments for CRC.